ICU, Calmette Hospital, University Hospital of Lille
Lille, Nord, 59037, France
NCT Number: NCT01082666
We hypothesized that continuous control of tracheal cuff pressure would reduce microaspiration of gastric content as determined by pepsin level in tracheal aspirate.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Phase 4
Lille, Nord, 59037, France
Randomized controlled open label study, performed in a 10-bed ICU. All patients intubated with a PVC-cuffed tracheal tube and receiving enteral nutrition who require at least 48 h of mechanical ventilation are eligible. Patients receive continuous control of cuff pressure using a pneumatic device (intervention group) or manual control using a manometer (control group). Target cuff pressure is 25 cmH2O.
In all patients, pepsin is measured in tracheal aspirate during a 48-h period after inclusion, as proxy for gastric content aspiration. In addition tracheobronchial colonization and ventilator associated pneumonia rates will be compared between the two groups.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Continuous control of cuff pressure using a pneumatic device (Nosten, Leved, France)
Other names: Automatic control of cuff pressure (Rusch, Kernen, Germany)
Manual control of cuff pressure is a routine practice in ICU patients
Other names: Manual manometer
Time frame: 48 h after randomization
Time frame: day 28 after randomization
University Hospital, Lille
Other
Phase 4 Study of Continuous Control of Tracheal Cuff Pressure and Microaspiration in Critically Ill Patients
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04957238
Aberrant Motor Behavior in Dementia, Agitation,Psychomotor
Aurillac, France
View Trial DetailsNCT07681544
Critical Illness, Critically Ill
Buenos Aires, Argentina
View Trial DetailsNCT04079387
Critical Illness, Critically Ill
Montpellier, Languedoc-Roussillon, France
View Trial DetailsNCT03681626
Critical Illness, Critically Ill
Rouen, France
View Trial Details